What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Immune system
- Gene
His primary areas of investigation include Immunology, Antibody, Internal medicine, Immune system and Arthritis.
His research brings together the fields of Genotype and Immunology.
His study in Antibody is interdisciplinary in nature, drawing from both Streptococcus pneumoniae, Microbiology, Molecular biology, Receptor and Tetanus.
His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology, Endocrinology and Surgery.
In his research, Gene rearrangement, Transplantation, Graft-versus-host disease, Stem cell and Blood cell is intimately related to Peripheral blood mononuclear cell, which falls under the overarching field of Arthritis.
Ger T. Rijkers has researched Vaccination in several fields, including Haemophilus influenzae, Haemophilus, Antibody titer, Pneumococcal infections and Conjugate vaccine.
His most cited work include:
- A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2 -/- γc -/- double-mutant mice (160 citations)
- Lack of isoprenoid products raises ex vivo interleukin‐1β secretion in hyperimmunoglobulinemia D and periodic fever syndrome (140 citations)
- Successful treatment of allergic bronchopulmonary aspergillosis with recombinant anti-IgE antibody (128 citations)
What are the main themes of his work throughout his whole career to date?
His primary areas of study are Immunology, Internal medicine, Antibody, Vaccination and Immune system.
His Immunology research includes elements of Streptococcus pneumoniae and Virology.
His Internal medicine study incorporates themes from Gastroenterology, Endocrinology and Probiotic.
His research integrates issues of Molecular biology, Tetanus, Microbiology and Spleen in his study of Antibody.
The study incorporates disciplines such as Pneumococcal vaccine, Antibody titer, Pneumococcal conjugate vaccine and Conjugate vaccine in addition to Vaccination.
Ger T. Rijkers has included themes like T cell, B cell and B-1 cell in his Antigen study.
He most often published in these fields:
- Immunology (55.70%)
- Internal medicine (21.84%)
- Antibody (17.72%)
What were the highlights of his more recent work (between 2017-2021)?
- Immunology (55.70%)
- Internal medicine (21.84%)
- Coronavirus disease 2019 (3.48%)
In recent papers he was focusing on the following fields of study:
His main research concerns Immunology, Internal medicine, Coronavirus disease 2019, Clinical trial and Immune system.
His Immunology study frequently draws connections to adjacent fields such as Interstitial lung disease.
The concepts of his Internal medicine study are interwoven with issues in Probiotic, Lactobacillus rhamnosus, Antibiotics, Specific antibody and Placebo.
His work on Severe acute respiratory syndrome coronavirus 2 as part of general Coronavirus disease 2019 study is frequently connected to Persistence, therefore bridging the gap between diverse disciplines of science and establishing a new relationship between them.
His research in Clinical trial intersects with topics in Community-acquired pneumonia, Adjunctive treatment and Oral dexamethasone.
The Immune checkpoint inhibitors, Tumor immunology and Immunotherapy research Ger T. Rijkers does as part of his general Immune system study is frequently linked to other disciplines of science, such as Fecal bacteriotherapy, therefore creating a link between diverse domains of science.
Between 2017 and 2021, his most popular works were:
- Differences in Antibody Kinetics and Functionality Between Severe and Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infections. (36 citations)
- A practical guide for probiotics applied to the case of antibiotic-associated diarrhea in The Netherlands (25 citations)
- Wheezing and infantile colic are associated with neonatal antibiotic treatment. (15 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Immune system
- Gene
Ger T. Rijkers mainly investigates Immunology, Internal medicine, Environmental health, Severe acute respiratory syndrome coronavirus 2 and Antibiotics.
He regularly ties together related areas like Community-acquired pneumonia in his Immunology studies.
His Internal medicine study combines topics from a wide range of disciplines, such as Probiotic and Lactobacillus rhamnosus.
His work carried out in the field of Severe acute respiratory syndrome coronavirus 2 brings together such families of science as Titer and Immune system.
His Antibiotics research incorporates themes from Meta-analysis, Relative risk, Physiology and Bacteroidetes.
In his study, Pneumonia is inextricably linked to Antigen, which falls within the broad field of Coronavirus disease 2019.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
